Skip to main content
Caplight Logo









aescolab

aescolab

Private
BerlinHealthcare & Life Scienceshttps://www.aescolab.de/en

Last Round

Seed

Jun 3, 2025

Company Overview

aescolab is a healthtech company that provides high-quality blood biomarker analyses and personalized lifestyle recommendations to help individuals and employees improve their energy and well-being.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, D2C Brands, HR

Business Model

B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

blood biomarker analysispersonalized healthpreventive healthhealth optimizationbiohackinghealthtechcorporate wellnessemployee health programsdigital health platformlongevitydata-driven healthabsenteeism reductionwellness techD2Cdirect-to-consumer health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

aescolab Comparables

Compare aescolab with similar companies based on industry and business-model similarity.

aescolab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HealthCaters
80%
Cerascreen
79%
Aniva Health
78%

aescolab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 3, 2025
VC RoundApr 6, 2025
SeedNov 1, 2024

Key People

Founding team and executive leadership

Ruth Biallowons

Chief Medical Officer And Co-Founder

Founding Team

Tobias Moertel

COO Co-Founder

Founding Team

Stephan Alexander Dreier

Chief Executive Officer & Co-Founder

Founding Team

Bruno Fischetti

Chief Technology Officer

Executive Team

aescolab Investors

Notable investors and investment history

aescolab investors
InvestorRounds
KRINGVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 36% QoQ, from 14 to 19 employees.

  • Jan 23, 2026

    Grew 36% QoQ, from 14 to 19 employees.

aescolab Filings

Explore SEC and related filing metadata, where available.

aescolab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about aescolab's valuation, stock price, and market status.

Is aescolab a public or private company?

aescolab is a private company.

What is the current stock price of aescolab?

aescolab is a private company with no public stock price. No recent secondary market data is available.

How much is aescolab worth (valuation)?

Valuation information for aescolab is not publicly available.

Can I buy aescolab stock?

aescolab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was aescolab's last funding round?

aescolab's most recent funding round was VC Round on April 6, 2025.

Who are the main investors in aescolab?

Key investors in aescolab include KRING.

Will aescolab IPO soon?

No public IPO plans have been announced for aescolab.

How can I track aescolab secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor aescolab's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range14
Year Founded2024
Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?